A citation-based method for searching scientific literature




K V S Hari Kumar, Altamash Shaikh, Pitambar Prusty. Diabetes Res Clin Pract 2013
Times Cited: 61




List of shared articles



Times cited

Combination of vitamin D and dipeptidyl peptidase-4 inhibitors (VIDPP-4i) as an immunomodulation therapy for autoimmune diabetes.
Marcelo Maia Pinheiro, Felipe Moura Maia Pinheiro, Susana Nogueira Diniz, Andrea Fabbri, Marco Infante. Int Immunopharmacol 2021
1

Combining MK626, a novel DPP-4 inhibitor, and low-dose monoclonal CD3 antibody for stable remission of new-onset diabetes in mice.
Lei Ding, Conny A Gysemans, Geert StangĂ©, Yves Heremans, Yixing Yuchi, Tatiana Takiishi, Hannelie Korf, Marie Chintinne, Richard D Carr, Harry Heimberg,[...]. PLoS One 2014
15

DPP-4 Inhibitors as Treatments for Type 1 Diabetes Mellitus: A Systematic Review and Meta-Analysis.
Qixian Wang, Min Long, Hua Qu, Rufei Shen, Rui Zhang, Jing Xu, Xin Xiong, Hui Wang, Hongting Zheng. J Diabetes Res 2018
20

GLP-1 Receptor Agonists and Type 1 Diabetes - Where Do We Stand?
Djordje S Popovic, Edita Stokic, Stevan L Popovic. Curr Pharm Des 2015
4

Dipeptidyl peptidase 4 inhibitors and their potential immune modulatory functions.
Shiying Shao, QinQin Xu, Xuefeng Yu, Ruping Pan, Yong Chen. Pharmacol Ther 2020
38



Dipeptidyl peptidase-4(DPP-4) inhibitors: promising new agents for autoimmune diabetes.
Xia Wang, Peilin Zheng, Gan Huang, Lin Yang, Zhiguang Zhou. Clin Exp Med 2018
16